Cargando…
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies
Metastatic melanoma patients carrying a BRAF(V600) mutation can be treated with a combination of BRAF and MEK inhibitors (BRAFi/MEKi), but innate and acquired resistance invariably occurs. Predicting patient response to targeted therapies is crucial to guide clinical decision. We describe here the d...
Autores principales: | Jarrosson, Loraine, Dalle, Stéphane, Costechareyre, Clélia, Tang, Yaqi, Grimont, Maxime, Plaschka, Maud, Lacourrège, Marjorie, Teinturier, Romain, Le Bouar, Myrtille, Maucort‐Boulch, Delphine, Eberhardt, Anaïs, Castellani, Valérie, Caramel, Julie, Delloye‐Bourgeois, Céline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994476/ https://www.ncbi.nlm.nih.gov/pubmed/36692026 http://dx.doi.org/10.15252/emmm.202216629 |
Ejemplares similares
-
An avian embryo patient-derived xenograft model for preclinical studies of human breast cancers
por: Jarrosson, Loraine, et al.
Publicado: (2021) -
P1243: FUNCTIONAL PRECISION ONCOLOGY FOR FOLLICULAR LYMPHOMA WITH PATIENT-DERIVED XENOGRAFT IN AVIAN EMBRYOS.
por: Zala, Manon, et al.
Publicado: (2023) -
Environmental cues from neural crest derivatives act as metastatic triggers in an embryonic neuroblastoma model
por: Ben Amar, Dounia, et al.
Publicado: (2022) -
ZEB1 transcription factor promotes immune escape in melanoma
por: Plaschka, Maud, et al.
Publicado: (2022) -
Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth
por: Ménard, Marie, et al.
Publicado: (2018)